Reply to correspondence on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting” Antonio Bertoletti, Anthony T Tan Clinical and Molecular Hepatology.2025; 31(1): e113. CrossRef